Gastric protection and garstrointestinal bleeding with aspirin thromboprophylaxis in hip and knee joint replacements

Annals of the Royal College of Surgeons of England

Volumn 90, Issue 4, 2008, Pages 332-335

  Madhusudhan, T R ^a,b   Rangan, A ^a   Gregg, P J ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b GLAN CLWYD HOSPITAL   (United Kingdom)

Author keywords

Aspirin; Gastrointestinal bleeding; Histamine blockers

Indexed keywords

ACETYLSALICYLIC ACID; CEFUROXIME; RANITIDINE; STEROID; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HIP ARTHROPLASTY; HIP DISEASE; HUMAN; KNEE ARTHROPLASTY; KNEE DISEASE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; RETROSPECTIVE STUDY; STOMACH PROTECTION; TREATMENT DURATION; UNITED KINGDOM; UNIVERSITY HOSPITAL; UPPER GASTROINTESTINAL BLEEDING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG COMBINATION; GASTROINTESTINAL HEMORRHAGE; MULTICENTER STUDY; RISK FACTOR; THROMBOEMBOLISM;

AGED; ANTI-ULCER AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; RANITIDINE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 44649114716     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588408X285946     Document Type: Article

References (17)

1. Scottish Intercollegiate Guidelines Network. Prophylaxis of Venous Thromboembolism, a National Clinical Guideline, 62, 2002; .
2. Hardman JG, Limbird LE. (eds) In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edn. New York: McGraw-hill, 2001:p1534.
3. Hawkey CJ. Aspirin and GI bleeding. Aliment Pharmacol Ther 1994; 8: 141-6.
4. Farrel B, Goodwin J, Richards S, Warlow C. The United Kingdom transient ischaernic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-54.
5. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N Engl J Med 1974; 290; 1158-62.
6. Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 1993; 35: 219-26.
7. Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986; 104: 390-8.
8. Graham DY, Smith JL, Spiut HJ, Torres E. Gastric adaptation studies in humans during continuous aspirin administration. Gastroenterology 1988; 95: 327-33.
9. Shorrock CJ, Rees DW. Effect of indomethacin on human gastroduodenal 'mucous bicarbonate' barrier. Gut 1987; 28: A1411
10. Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G. Aspirin and other platelet-active drugs. The relationship among dose, effectiveness and side effects. Chest 1995; 108: 247s-257s.
11. Hawkey CJ, Somerville KW, Marshall S. Prophylaxis of aspirin induced gastric mucosal bleeding with ranitidine. Aliment Pharmacol Ther 1988; 2: 245-52
12. Lotke PA, Lonner JH. Deep venous thrombosis prophylaxis: better living through chemistry - in opposition. J Arthrosplasty 2005; 20(Suppl 2): 157.
13. Anon. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 2000; 355: 1288-9.
14. Gillespie W, Murray D, Gregg PJ, Warwick D. Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery. J Bone Joint Surg Br 2000; 82: 475-9.
15. Griffin SM, Raimes SA. Upper Gastrointestinal Surgery, A Companion to Specialist Surgical Practice, 2nd edn. New York: WB Saunders, 2001; p338.
16. Monreal M, Lafoz E, Roca J, Granero X, Soler J, Salazar X, Olazabal A et al. Platelet count, antiplatelet therapy and pulmonary embolism - a prospective study in patients with hip surgery. Thromb Haemostat 1995; 73: 380-5.
17. Taha AS, Angerson WJ, Knill-Jone RP, Blatchford O. Upper gastrointestinal mucosal abnormalities and blood loss complicating low dose aspirin and antithrombotic therapy. Aliment Pharmacol Ther 2006; 23: 489-95.